-
Particle Sciences Receives Patent for its Surface Arrayed Therapeutics™ Drug Delivery Platform
Particle Sciences has received a Notice of Allowance for its SATx™ platform, which has utility in applications ranging from oncology to vaccines. The SATx™ technology is a disruptive nanoparticle platform that helps clients improve the potency, safety, and utility of both large and small molecule therapeutics. Read more: http://prn.to/1CbkEhf
-
Orbweaver Founder Featured in Keystone Edge
The industry responsible for producing some of the highest-tech products, like missiles and sophisticated cell phones, was using some very low-tech methods when it came to ordering parts. Orbweaver developed a sophisticated supply-chain management software that is disrupting the industry. Read more: http://bit.ly/1O3nnkl